Metraipolis › archive › dc_b74ee9ef9666

Denosumab Combined With PARP Inhibitors and Chemoradiotherapy for Treating Triple Negative Breast Cancer With Bone Metastasis: A Case Report — Europe PMC PMID:41792913

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41792913
DOI
10.1002/cnr2.70463
License (as archived)
solo-consultazione
Archived
2026-11-05T11:14:20.354Z
SHA-256 of the archived text
2e48a54de2df586e0d6d3296aa06a9ca057fa71146687af04e8646b3d009016c
Stable URL of this page
https://metraipolis.com/documento/dc_b74ee9ef9666

How to cite

Denosumab Combined With PARP Inhibitors and Chemoradiotherapy for Treating Triple Negative Breast Cancer With Bone Metastasis: A Case Report — Europe PMC PMID:41792913 — Europe PMC (en), https://europepmc.org/article/MED/41792913 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_b74ee9ef9666 (Metraipolis archive dc_b74ee9ef9666, sha256 2e48a54de2df586e0d6d3296aa06a9ca057fa71146687af04e8646b3d009016c)
BibTeX
@misc{dcb74ee9ef9666,
  title = {Denosumab Combined With PARP Inhibitors and Chemoradiotherapy for Treating Triple Negative Breast Cancer With Bone Metastasis: A Case Report — Europe PMC PMID:41792913},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41792913},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_b74ee9ef9666; sha256 2e48a54de2df586e0d6d3296aa06a9ca057fa71146687af04e8646b3d009016c},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41792913. Agents can read the archived copy with the MCP tool read_document.